Apr 30, 2024

Phreesia Q1 2025 Earnings Report

Phreesia's financial results for the fiscal first quarter ended April 30, 2024, were announced, showing revenue growth and a reduced net loss.

Key Takeaways

Phreesia reported a 21% year-over-year increase in total revenue, reaching $101.2 million. The net loss decreased significantly to $19.7 million, and Adjusted EBITDA was $4.1 million. The company updated its fiscal year 2025 revenue outlook to $416 million to $426 million and Adjusted EBITDA outlook to $21 million to $26 million.

Total revenue increased by 21% year-over-year to $101.2 million.

The average number of healthcare services clients (AHSCs) increased by 23% year-over-year to 4,065.

Net loss decreased from $37.5 million to $19.7 million year-over-year.

Adjusted EBITDA improved to $4.1 million from negative $13.8 million year-over-year.

Total Revenue
$101M
Previous year: $83.8M
+20.7%
EPS
-$0.35
Previous year: -$0.7
-50.0%
Patient Payment Volume
$1.17B
Previous year: $1.02B
+14.8%
Gross Profit
$60.3M
Previous year: $52.8M
+14.2%
Cash and Equivalents
$79.5M
Previous year: $150M
-46.9%
Free Cash Flow
-$1.53M
Previous year: -$15M
-89.8%
Total Assets
$372M
Previous year: $354M
+5.2%

Phreesia

Phreesia

Phreesia Revenue by Segment

Forward Guidance

Phreesia updated its revenue outlook for fiscal year 2025 to a range of $416 million to $426 million and its Adjusted EBITDA outlook to a range of $21 million to $26 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income